Merck 1st-quarter revenues up 6 percent

By

Merck, the pharmaceutical giant with a plant in West Point, Montgomery County, reports total revenues of $10.04 billion for the first quarter of 2018. (Photo courtesy of flickr.com.)

Drugmaker Merck ‘s posted first quarter revenues of $10.04 billion this week, an increase of 6 percent driven by a jump in sales of cancer blockbuster Keytruda.

However,  a $1.4 billion charge for starting a research partnership with Japanese drugmaker Eisai dragged down profits by more than half, writes Linda A. Johnson at philly.com.

[uam_ad id=”54865″]


Merck executives said they have plenty of money to do a deal of any size, with about $20 billion of cash on hand and room to borrow more, but they’re not necessarily looking for a mega-deal. They also stressed that Merck’s animal health business, which analysts have been pressing it to divest, provides both diversification and synergies with research in the human health division.
To read the full story, click here.
[uam_ad id=”54875″]

 

Stay Connected, Stay Informed

Subscribe for great stories in your community!

"*" indicates required fields

Hidden
MT Yes
This field is for validation purposes and should be left unchanged.
Advertisement